EXAGEN INC. — Director's Dealing 2021

Jun 21, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EXAGEN INC. (XGN)
CIK: 0001274737
Period of Report: 2021-06-17

Reporting Person: Stokes Frank (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-06-17	Stock Option(right to buy)	$16.41	A	15000	Acquired	2031-06-16	Common Stock (15000.0)	Direct

Footnotes

F1: The option is exercisable as it vests. The total number of shares of common stock subject to the option vests in 36 equal monthly installments over the three-year period beginning on July 17, 2021, subject to the Reporting Person's continued service to the Issuer through each such vesting date.